Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort DocWire News
The House's new drug plan is 31 times as deadly as COVID-19 to date | TheHill The Hill
Sage Therapeutics, Biogen highlight data showing zuranolone well-tolerated in MDD Healio
Michael J Fox Foundation funds ketamine trial to treat patients with PD, depression Healio
It's Time for Us to Stop Waffling About Psychiatry Psychiatric Times
Cognitive Behavior Therapy May Help Individuals with Depression, AIDS/HIV Pharmacy Times
Mechanisms of Action of Ketamine and Esketamine | American Journal of Psychiatry Am J Psychiatry
New Insights Into Major Depression and the Treatment of Bipolar Depression | American Journal of Psychiatry Am J Psychiatry
Ketamine After Two Antidepressants? | American Journal of Psychiatry Am J Psychiatry
